A prospective cohort study to assess seroprevalence, incidence, knowledge, attitudes and practices, willingness to pay for vaccine and related risk factors in dengue in a high incidence setting

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Martínez Vega, Ruth Aralí ^a,b   Rodriguez Morales, Alfonso J ^a,c   Bracho Churio, Yalil Tomás ^a   Castro Salas, Mirley Enith ^a   Galvis Ovallos, Fredy ^a   Díaz Quijano, Ronald Giovanny ^a   Luna González, María Lucrecia ^a   Castellanos, Jaime E ^d   Ramos Castañeda, José ^e   Diaz Quijano, Fredi Alexander ^f  

^a Organización Latinoamericana Para El Fomento de la Investigación en Salud OLFIS   (Colombia)

^b UNIVERSIDAD DE SANTANDER   (Colombia)

^c UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

^d UNIVERSIDAD EL BOSQUE   (Colombia)

^e INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Colombia; Dengue; Incidence; Knowledge; Risk factors; Seroprevalence; Vaccines

Indexed keywords

DENGUE VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACCESS TO INFORMATION; ADULT; AEDES AEGYPTI; AEDES ALBOPICTUS; ARTICLE; ATTITUDE TO ILLNESS; CARIBBEAN; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; HEALTH CARE PRACTICE; HEALTH ECONOMICS; HUMAN; INCIDENCE; INFECTION RISK; INFORMATION PROCESSING; MORBIDITY; MORTALITY; NONHUMAN; POPULATION ABUNDANCE; POPULATION DENSITY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; VECTOR CONTROL; VECTOR DENSITY; VIRUS TRANSMISSION; WILLINGNESS TO PAY; ADOLESCENT; AGED; ATTITUDE TO HEALTH; CHILD; CLINICAL TRIAL; COLOMBIA; CROSS-SECTIONAL STUDY; ECONOMICS; HEALTH SERVICE; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RISK FACTOR; SEROEPIDEMIOLOGY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; COLOMBIA; CROSS-SECTIONAL STUDIES; DENGUE; DENGUE VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84997190935     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-2055-4     Document Type: Article

References (52)

1. Alfaro-Toloza P, Clouet-Huerta DE, Rodriguez-Morales AJ. Chikungunya, the emerging migratory rheumatism. Lancet Infect Dis. 2015;15(5):510-2.
2. Rodriguez-Morales AJ. Zika: the new arbovirus threat for latin America. J Infect Dev Ctries. 2015;9(6):684-5.
3. Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the global burden of disease study 2013. Lancet Infect Dis. 2016;16(6):712-23.
4. Castro Rodriguez R, Carrasquilla G, Porras A, Galera-Gelvez K, Lopez Yescas JG, Rueda-Gallardo JA. The burden of dengue and the financial cost to Colombia, 2010-2012. AmJTrop Med Hyg. 2016;94(5):1065-72.
5. Gubler DJ. The economic burden of dengue. AmJTrop Med Hyg. 2012;86(5):743-4.
6. Martelli CM, Siqueira Jr JB, Parente MP, Zara AL, Oliveira CS, Braga C, et al. Economic impact of dengue: multicenter study across four Brazilian Regions. PLoS Negl Trop Dis. 2015;9(9):e0004042.
7. Shepard DS, Undurraga EA, Betancourt-Cravioto M, Guzman MG, Halstead SB, Harris E, et al. Approaches to refining estimates of global burden and economics of dengue. PLoS Negl Trop Dis. 2014;8(11):e3306.
8. Undurraga EA, Betancourt-Cravioto M, Ramos-Castaneda J, Martinez-Vega R, Mendez-Galvan J, Gubler DJ, et al. Economic and disease burden of dengue in Mexico. PLoS Negl Trop Dis. 2015;9(3):e0003547.
9. Alcala L, Quintero J, Gonzalez-Uribe C, Brochero H. Estimation of aedes aegypti (L.) (diptera: culicidae) productivity in households and public spaces in a dengue endemic City in Colombia. Biomedica. 2015;35(2):258-68.
10. Londono-Renteria B, Cardenas JC, Giovanni JE, Cardenas L, Villamizar P, Rolon J, et al. Aedes aegypti anti-salivary gland antibody concentration and dengue virus exposure history in healthy individuals living in an endemic area in Colombia. Biomedica. 2015;35(4):572-81.
11. Olano VA, Matiz MI, Lenhart A, Cabezas L, Vargas SL, Jaramillo JF, et al. Schools as potential risk sites for vector-borne disease transmission: mosquito vectors in rural schools in Two municipalities in Colombia. J Am Mosq Control Assoc. 2015;31(3):212-22.
12. Carrington LB, Nguyen HL, Nguyen NM, Duong TH, Tuan TV, Giang NT, et al. Naturally-acquired dengue virus infections do not reduce short-term survival of infected Aedes aegypti from Ho Chi Minh City, Vietnam. AmJTrop Med Hyg. 2015;92(3):492-6.
13. Villar LA, Rojas DP, Besada-Lombana S, Sarti E. Epidemiological trends of dengue disease in Colombia (2000-2011): a systematic review. PLoS Negl Trop Dis. 2015;9(3):e0003499.
14. PAHO. Number of Reported Cases of Dengue and Severe Dengue (SD) in the Americas, by Country: Figures for 2014 2015 [Available from: http://bit.ly/1J8zn1v. Accessed 22 Nov 2016.
15. PAHO. Number of Reported Cases of Dengue and Severe Dengue (SD) in the Americas, by Country: Figures for 2015 2016 [Available from: http://www.paho.org/hq/index.php?option=com_docman&task=doc_download&Itemid=&gid=32911&lang=es. Accessed 22 Nov 2016.
16. Padilla JC, Rojas DP, Gómez RS. Dengue en Colombia. Bogotá: Guias de impresión LTDA; 2012.
17. Koh BK, Ng LC, Kita Y, Tang CS, Ang LW, Wong KY, et al. The 2005 dengue epidemic in Singapore: epidemiology, prevention and control. Ann Acad Med Singap. 2008;37(7):538-45.
18. Lee IK, Liu JW, Yang KD. Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. AmJTrop Med Hyg. 2009;80(4):651-5.
19. Vera-Polania F, Perilla-Gonzalez Y, Martinez-Pulgarin DF, Baquero-Rodriguez JD, Munoz-Urbano M, Lagos-Gallego M, et al. Bibliometric assessment of the Latin-American contributions in dengue. Recent Pat Antiinfect Drug Discov. 2014;9(3):195-201.
20. Chevillon C, Failloux AB. Questions on viral population biology to complete dengue puzzle. Trends Microbiol. 2003;11(9):415-21.
21. Braga C, Luna CF, Martelli CM, de Souza WV, Cordeiro MT, Alexander N, et al. Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife. Brazil Acta tropica. 2010;113(3):234-40.
22. Stoddard ST, Morrison AC, Vazquez-Prokopec GM, Paz Soldan V, Kochel TJ, Kitron U, et al. The role of human movement in the transmission of vector-borne pathogens. PLoS Negl Trop Dis. 2009;3(7):e481.
23. Adams B, Holmes EC, Zhang C, Mammen Jr MP, Nimmannitya S, Kalayanarooj S, et al. Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A. 2006;103(38):14234-9.
24. Mattar S, Morales V, Cassab A, Rodriguez-Morales AJ. Effect of climate variables on dengue incidence in a tropical Caribbean municipality of Colombia, Cerete, 2003-2008. Int J Infect Dis. 2013;17(5):e358-9.
25. Quintero-Herrera LL, Ramirez-Jaramillo V, Bernal-Gutierrez S, Cardenas-Giraldo EV, Guerrero-Matituy EA, Molina-Delgado AH, et al. Potential impact of climatic variability on the epidemiology of dengue in Risaralda, Colombia, 2010-2011. J Infect Public Health. 2015;8(3):291-7.
26. Matthias J, Zielinski-Gutierrez EC, Tisch DJ, Stanek D, Blanton RE, Doyle MS, et al. Evaluating public housing residents for knowledge, attitudes, and practices following dengue prevention outreach in Key West, Florida. Vector Borne Zoonotic Dis. 2014;14(11):788-93.
27. Seng CM, Jute N. Breeding of Aedes aegypti (L.) and Aedes albopictus (Skuse) in urban housing of Sibu town, Sarawak. Southeast Asian J Trop Med Public Health. 1994;25(3):543-8.
28. Siqueira JB, Martelli CM, Maciel IJ, Oliveira RM, Ribeiro MG, Amorim FP, et al. Household survey of dengue infection in central Brazil: spatial point pattern analysis and risk factors assessment. AmJTrop Med Hyg. 2004;71(5):646-51.
29. Duong V, Lambrechts L, Paul RE, Ly S, Lay RS, Long KC, et al. Asymptomatic humans transmit dengue virus to mosquitoes. Proc Natl Acad Sci U S A. 2015;112(47):14688-93.
30. Iturrino-Monge R, Avila-Aguero ML, Avila-Aguero CR, Moya-Moya T, Canas-Coto A, Camacho-Badilla K, et al. Seroprevalence of dengue virus antibodies in asymptomatic Costa Rican children, 2002-2003: a pilot study. Rev Panam Salud publica. 2006;20(1):39-43.
31. Jamjoom GA, Azhar EI, Kao MA, Radadi RM. Seroepidemiology of asymptomatic dengue virus infection in Jeddah, Saudi Arabia. Virol. 2016;7:1-7.
32. Olaiz G, Franco A, Palma O, Echarri C, Valdez R, Herrera C. Methodological design for the national survey violence against women in Mexico. Salud Publica Mex. 2006;48 Suppl 2:S328-35.
33. Blacksell SD, Jarman RG, Gibbons RV, Tanganuchitcharnchai A, Mammen Jr MP, Nisalak A, et al. Comparison of seven commercial antigen and antibody enzyme-linked immunosorbent assays for detection of acute dengue infection. Clin Vaccine Immunol. 2012;19(5):804-10.
34. Vikram K, Nagpal BN, Pande V, Srivastava A, Saxena R, Anvikar A, et al. An epidemiological study of dengue in Delhi. India Acta Trop. 2016;153:21-7.
35. Groen J, Koraka P, Velzing J, Copra C, Osterhaus AD. Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin Diagn Lab Immunol. 2000;7(6):867-71.
36. Chew CH, Woon YL, Amin F, Adnan TH, Abdul Wahab AH, Ahmad ZE, et al. Rural-urban comparisons of dengue seroprevalence in Malaysia. BMC Public Health. 2016;16(1):824.
37. Yew YW, Ye T, Ang LW, Ng LC, Yap G, James L, Chew SK, Goh KT. Seroepidemiology of dengue virus infection among adults in Singapore. Ann Acad Med Singapore. 2009;38(8):667-75.
38. Ratnam I, Black J, Leder K, Biggs BA, Matchett E, Padiglione A, et al. Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia. Eur J Clin Microbiol Infect Dis. 2012;31(6):1203-10.
39. Lo CL, Yip SP, Leung PH. Seroprevalence of dengue in the general population of Hong Kong. Trop Med Int Health. 2013;18(9):1097-102.
40. Low SL, Lam S, Wong WY, Teo D, Ng LC, Tan LK. Dengue seroprevalence of healthy adults in Singapore: serosurvey among blood donors, 2009. Am J Trop Med Hyg. 2015;93(1):40-5.
41. Caceres-Manrique Fde M, Vesga-Gomez C, Perea-Florez X, Ruitort M, Talbot Y. Knowledge, attitudes and practice regarding dengue in two neighborhoods in Bucaramanga, Colombia. Rev Salud Publica. 2009;11(1):27-38.
42. Lee JS, Mogasale V, Lim JK, Carabali M, Sirivichayakul C, Anh DD, et al. A multi-country study of the household willingness-to-Pay for dengue vaccines: household surveys in Vietnam, Thailand, and Colombia. PLoS Negl Trop Dis. 2015;9(6):e0003810.
43. Pérez-Castro R, Castellanos JE, Olano VA, Matiz MI, Jaramillo JF, Vargas SL, Sarmiento DM, Stenström TA, Overgaard HJ. Detection of all four dengue serotypes in Aedes aegypti female mosquitoes collected in a rural area in Colombia. Mem Inst Oswaldo Cruz. 2016;111(4):233-40. doi: 10.1590/0074-02760150363.
44. Sanchez-Seco MP, Rosario D, Domingo C, Hernandez L, Valdes K, Guzman MG, et al. Generic RT-nested-PCR for detection of flaviviruses using degenerated primers and internal control followed by sequencing for specific identification. J Virol Methods. 2005;126(1-2):101-9.
45. Larrieu S, Cassadou S, Rosine J, Chappert JL, Blateau A, Ledrans M, et al. Lessons raised by the major 2010 dengue epidemics in the French West Indies. Acta Trop. 2014;131:37-40.
46. Arroyave E, Londono AF, Quintero JC, Agudelo-Florez P, Arboleda M, Diaz FJ, et al. Etiology and epidemiological characterization of non-malarial febrile syndrome in three municipalities of Uraba (Antioquia), Colombia. Biomedica. 2013;33 Suppl 1:99-107.
47. WHO. Summary of the April 2016 meeting of the Strategic Advisory Group of Experts on immunization (SAGE). Geneva: World Health Organization; 2016. Available from: http://www.who.int/immunization/policy/sage/en/.
48. Bijkerk P, Fanoy EB, Kardamanidis K, van der Plas SM, Te Wierik MJ, Kretzschmar ME, et al. To notify or not to notify: decision aid for policy makers on whether to make an infectious disease mandatorily notifiable. Euro Surveill. 2015;20(34):30003.
49. Vajta B, Holberg M, Mills J, McBride WJ. Weighing up the costs of seeking health care for dengue symptoms: a grounded theory study of backpackers' decision-making processes. Aust J Prim Health. 2015;21(2):245-8.
50. Ocampo CB, Gonzalez C, Morales CA, Perez M, Wesson D, Apperson CS. Evaluation of community-based strategies for Aedes aegypti control inside houses. Biomedica. 2009;29(2):282-97.
51. Romero-Vivas CM, Falconar AK. Investigation of relationships between Aedes aegypti egg, larvae, pupae, and adult density indices where their main breeding sites were located indoors. J Am Mosq Control Assoc. 2005;21(1):15-21.
52. Martinez-Vega RA, Danis-Lozano R, Diaz-Quijano FA, Velasco-Hernandez J, Santos-Luna R, Roman-Perez S, et al. Peridomestic infection as a determining factor of dengue transmission. PLoS Negl Trop Dis. 2015;9(12):e0004296.